About the author
When it comes to infection prevention, we need a new normal. Norovirus impacts 19-21 million Americans and costs US$2 billion annually. Influenza impacts 30 to 40 million Americans and costs US$10.4 billion annually.
R-Zero developed a suite of solutions to greatly reduce the damage each of these viruses causes to our personal and economic health. We are establishing a new standard for public health.
R-Zero is a biosafety company dedicated to making safer spaces and common places. We design effective technologies and protocols to reduce deadly pathogens—today and forever.
Number Of Publications
CSP Status: Active
CSP Level: Gold